跳至主要内容
临床试验/jRCT2072230089
jRCT2072230089招募中不适用

Confirmatory trial with dMD-003 - Non-inferiority confirmatory study of dMD-003 to Seprafilm in patients with primary rectal cancer scheduled to undergo temporary loop ileostomy -

Mochida Pharmaceutical Co., Ltd.0 个研究点目标入组 150 人开始时间: 2024年1月12日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
150
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized Controlled Trial
干预模型
Parallel Assignment
主要目的
Treatment Purpose
盲法
Single Blind

入排标准

年龄范围
20age old over 至 No limit(—)
性别
All

入选标准

  • (1) Patients with initial and primary rectal cancer.
  • (2) Patients with cStage 0 to cStage III cancer.
  • (3) Patients who are scheduled to undergo laparoscopic or robot-assisted rectal resection in which a temporary ileostomy is scheduled to be performed.
  • Other criteria.

排除标准

  • (1) Patients who have previously undergone surgery in the abdominal cavity (excluding appendicitis surgery).
  • (2) Patients with cStage IV cancer.
  • (3) Patients who are scheduled to have samples removed from a site other than the midline incision.
  • Other criteria.

结局指标

主要结局

-

Presence or absence of adhesion.

次要结局

未报告次要终点

研究者

相似试验